Strategic Pharma and Biotech Consultants with Diverse, Real-World Experience

  • LinkedIn - White Circle
  • Twitter - White Circle
 

ABOUT ARCHBOW

Archbow is a strategic consulting practice for the pharma & biotech industry.

 

Our company was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse, real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. 

 

Archbow approaches every project as a unique partnership, looking beyond the traditional suite of services to deliver enduring solutions at every stage of your product’s lifecycle.

 

We know what it takes to propel brands to success.

 

PHARMACEUTICAL & BIOTECH CONSULTING SERVICES

 
map of Global pharmaceutical distribution network
Distribution Support
satepharmaceutical market intelligence radar
Market Intelligence
International Solutions
hand touching global pharmaceutical strategy
barriers to patient access
Patient Support
pharmaceutcal patient files
Payer Strategy
gant chart for pharmaceutical project management
Project Management

TEAM

 
Thanks again for the great work here. I enjoyed working with you and the team.  The work was high quality, and I’m sure our paths will continue to cross down the line.

— Senior Director at a Top 10 pharmaceutical company

CASE STUDIES

Pharma commercial channel stratey

BLOG

March 31, 2020

During the COVID-19 crisis, it is essential for drug manufacturers to start considering short-term relief for distributor partners and HCP offices. Begin by asking these questions.

March 23, 2020

What pharma and biotech professionals need to know about the Drug Supply Chain Security Act and new track-and-trace regulations. Full article published on Pharmaceutical Executive.

March 3, 2020

While the norm is to view an audit as a stressful, time-consuming experience, audits can paint a picture not visible to the naked eye and are a valuable exercise to gauge the current health of a pharmaceutical patient support program.

January 13, 2020

Q&A on how traditional pharmaceutical distribution must be transformed to meet the challenges of revolutionary Cell and Gene Therapies.

January 7, 2020

Pharmaceutical Executive worked with Archbow’s distribution experts, Kevin Cast, Rob Besse, and Paul Furgal, to find out which trends we should be watching as we welcome 2020.

November 19, 2019

A well-organized Ad Board can provide a pharmaceutical manufacturer with numerous advantages over traditional, structured market-research. These 5 essentials will help your next Ad Board be a success.

November 5, 2019

In a Q&A, Rob Besse shares his thoughts on making the leap from his family’s business to consulting, what manufacturers need to know before commercialization planning, and industry trends worth watching.

October 28, 2019

When manufacturers are planning the launch of a Buy-and-Bill product, there are certain steps that are imperative to include in the launch strategy and development of support services.

October 21, 2019

Determining if your HUB should be insourced, outsourced, or a hybrid of those two options is a big decision. And finding the right answer can determine the future success of your patient access program.

September 19, 2019

Before establishing an Expanded Access Program, it’s vital for manufacturers to align internally around several crucial program decisions. These five are key.

Please reload

CONTACT US

 

Let us know about your business, your goals, your challenges. We're experts at mapping out your path to success. Fill in the form below, email us, or give us a call. We'd love to hear from you.

  • LinkedIn - White Circle
  • Twitter - White Circle
U.S. office

4700 Millenia Blvd.
Suite 175
Orlando, FL 32839

info@archbow.com

(321) 355-2686

archbow map
Europe office

Dammstrasse 19

6300 Zug

Switzerland

info@archbow.com

+ 41 (0)41 723 23 70

© 2020 by Archbow Consulting LLC | info@archbow.com(321) 355-2686

Privacy Policy